- Home
- GDO vs EDAP Comparison
GDO vs EDAP Comparison
Compare GDO & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDO
- EDAP
- Stock Information
- Founded
- GDO 2009
- EDAP 1979
- Country
- GDO United States
- EDAP France
- Employees
- GDO N/A
- EDAP N/A
- Industry
- GDO Finance Companies
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GDO Finance
- EDAP Health Care
- Exchange
- GDO Nasdaq
- EDAP Nasdaq
- Market Cap
- GDO 84.5M
- EDAP 81.6M
- IPO Year
- GDO N/A
- EDAP 1997
- Fundamental
- Price
- GDO $11.36
- EDAP $2.65
- Analyst Decision
- GDO
- EDAP Strong Buy
- Analyst Count
- GDO 0
- EDAP 1
- Target Price
- GDO N/A
- EDAP $19.00
- AVG Volume (30 Days)
- GDO 39.4K
- EDAP 35.5K
- Earning Date
- GDO 01-01-0001
- EDAP 03-26-2025
- Dividend Yield
- GDO 9.81%
- EDAP N/A
- EPS Growth
- GDO N/A
- EDAP N/A
- EPS
- GDO N/A
- EDAP N/A
- Revenue
- GDO N/A
- EDAP $70,722,730.00
- Revenue This Year
- GDO N/A
- EDAP $6.96
- Revenue Next Year
- GDO N/A
- EDAP $15.53
- P/E Ratio
- GDO N/A
- EDAP N/A
- Revenue Growth
- GDO N/A
- EDAP 12.17
- 52 Week Low
- GDO $11.21
- EDAP $2.00
- 52 Week High
- GDO $13.04
- EDAP $8.50
- Technical
- Relative Strength Index (RSI)
- GDO 53.45
- EDAP 66.55
- Support Level
- GDO $11.34
- EDAP $2.46
- Resistance Level
- GDO $11.49
- EDAP $2.69
- Average True Range (ATR)
- GDO 0.08
- EDAP 0.15
- MACD
- GDO 0.02
- EDAP 0.03
- Stochastic Oscillator
- GDO 55.17
- EDAP 92.59
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.